Yuhan Corporation signed a strategic partnership agreement with AstraZeneca Korea regard to joint sales of Crestor

On Mar 12, Yuhan Corporation announced that they signed a strategic partnership agreement with AstraZeneca Korea (CEO Liz chaeteuwin) regard to joint sales of no.1 statin drug Crestor (ingredient: rosuvastatin) in domestic.

Through this agreement, starting from March, both companies will begin sales and marketing of the product in general hospitals, and Yuhan alone will begin sales and marketi...